ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6998
0.00%
Brent Oil
81.965
0.00%
Bitcoin
69,128.31
0.87%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Strongbridge Biopharma PLC (SBBP)

  7. Strongbridge Biopharma PLC (SBBP) Noticias

SBBP

Strongbridge Biopharma (SBBP)

Strongbridge Biopharma PLC
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SBBP
FechaHoraFuenteTítuloSímboloCompañía
11/02/202216:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SBBPStrongbridge Biopharma PLC
05/01/202211:51Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SBBPStrongbridge Biopharma PLC
05/01/202211:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SBBPStrongbridge Biopharma PLC
07/10/202105:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SBBPStrongbridge Biopharma PLC
05/10/202115:35Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SBBPStrongbridge Biopharma PLC
05/10/202115:28Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SBBPStrongbridge Biopharma PLC
05/10/202115:01GlobeNewswire Inc.Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.NASDAQ:SBBPStrongbridge Biopharma PLC
23/09/202115:01GlobeNewswire Inc.Strongbridge Biopharma plc Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc.NASDAQ:SBBPStrongbridge Biopharma PLC
13/09/202106:14Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SBBPStrongbridge Biopharma PLC
08/09/202115:01GlobeNewswire Inc.Strongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc.NASDAQ:SBBPStrongbridge Biopharma PLC
08/09/202108:00TipRanksUnderstanding Strongbridge’s Newly Added Risk FactorNASDAQ:SBBPStrongbridge Biopharma PLC
31/08/202106:30GlobeNewswire Inc.Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With XerisNASDAQ:SBBPStrongbridge Biopharma PLC
30/08/202116:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SBBPStrongbridge Biopharma PLC
30/08/202106:30GlobeNewswire Inc.Leading Independent Proxy Advisory Firm ISS Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With XerisNASDAQ:SBBPStrongbridge Biopharma PLC
05/08/202106:30GlobeNewswire Inc.Strongbridge Biopharma plc Reports Second Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:SBBPStrongbridge Biopharma PLC
02/08/202106:30GlobeNewswire Inc.Strongbridge Biopharma plc Announces Commencement of Mailing of Proxy StatementNASDAQ:SBBPStrongbridge Biopharma PLC
29/07/202116:00Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:SBBPStrongbridge Biopharma PLC
29/07/202107:15GlobeNewswire Inc.Strongbridge Biopharma plc Provides Announcement Under the Irish Takeover Rules for Relevant Securities in IssueNASDAQ:SBBPStrongbridge Biopharma PLC
29/07/202106:30GlobeNewswire Inc.Strongbridge Biopharma plc to Report Second Quarter 2021 Financial Results on August 5, 2021NASDAQ:SBBPStrongbridge Biopharma PLC
26/07/202115:01GlobeNewswire Inc.Strongbridge Biopharma plc Announces Dates of Special Shareholder Meetings in Connection with the Proposed Acquisition by Xeris Pharmaceuticals, Inc.NASDAQ:SBBPStrongbridge Biopharma PLC
19/07/202115:01GlobeNewswire Inc.Axogen, Inc. Appoints John H. Johnson to Board of DirectorsNASDAQ:SBBPStrongbridge Biopharma PLC
13/07/202106:30GlobeNewswire Inc.Strongbridge Biopharma plc Announces Publication of Long-term Efficacy and Safety Results for KEVEYIS® (dichlorphenamide) fo...NASDAQ:SBBPStrongbridge Biopharma PLC
09/07/202116:07Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SBBPStrongbridge Biopharma PLC
03/06/202115:01GlobeNewswire Inc.Strongbridge Biopharma plc Announces Issuance of Patent for RECORLEV® (levoketoconazole) for the Treatment of Cushing’s Sy...NASDAQ:SBBPStrongbridge Biopharma PLC
25/05/202108:42TipRanksStrongbridge Shares Jump 12% on Acquisition Deal with XerisNASDAQ:SBBPStrongbridge Biopharma PLC
24/05/202115:58PR Newswire (US)Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creati...NASDAQ:SBBPStrongbridge Biopharma PLC
13/05/202106:30GlobeNewswire Inc.Strongbridge Biopharma plc Announces U.S. Food & Drug Administration (FDA) Filing Acceptance of New Drug Application (NDA) fo...NASDAQ:SBBPStrongbridge Biopharma PLC
12/05/202106:30GlobeNewswire Inc.Strongbridge Biopharma plc Reports First Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:SBBPStrongbridge Biopharma PLC
06/05/202106:30GlobeNewswire Inc.Strongbridge Biopharma plc to Host First Quarter 2021 Financial Results Conference Call on May 12, 2021NASDAQ:SBBPStrongbridge Biopharma PLC
14/04/202107:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SBBPStrongbridge Biopharma PLC
 Showing the most relevant articles for your search:NASDAQ:SBBP

Su Consulta Reciente

TSX
IAF.PR.G
Industrial Alliance Insu...
NASDAQ
ABAOWXX
Hsbc Usa Inc Autocallabl...
NASDAQ
FVTPYX
Innovative Technology Po...
NASDAQ
ABALZXX
Hsbc Bank Usa Na Capped ...
EU
VPDAH
Ville de Paris VPARIS3.0...
NASDAQ
AAYVIXX
Hsbc Usa Inc Issuer Call...
LSE
96DV
Vattfall 39
NYSE
MTBA
Simplify Exchang
AMEX
SDYL
ETRACS Monthly Pay 2xLev...
BOV
P2ST34
Pure Storage
AMEX
NZX
Nuveen Georgia Div
BOV
GMAT3R
Grupo Mateus ON
TSX
NOVC
Nova Cannabis
ASX
GML
Gateway Mining
TSXV
RJ.H
Rojo Resources
COIN
STEEMBTC
Steem
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados